4//SEC Filing
Parker Geoffrey M. 4
Accession 0001737287-24-000065
CIK 0001737287other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 4:21 PM ET
Size
309.8 KB
Accession
0001737287-24-000065
Insider Transaction Report
Form 4
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-10-21$2.84/sh−36,404$103,387→ 1,131,988 total
Footnotes (3)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Includes 3,974 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program.
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001491874
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 4:21 PM ET
- Size
- 309.8 KB